• 
  Ilayda Görgülü, Vinita Jagannath, Stéphanie Pons, Filip Koniuszewski, Matthias Groszer, et al.. The human‐specific nicotinic receptor subunit CHRFAM7A reduces α7 receptor function in human induced pluripotent stem cells‐derived and transgenic mouse neurons. European Journal of Neuroscience, 2024, 60 (5), pp.4893-4906. ⟨10.1111/ejn.16474⟩. ⟨pasteur-04751838⟩
• 
  Wahid Boukouaci, Mohamed Lajnef, Ching-Lien Wu, Jihène Bouassida, Kaori Saitoh, et al.. B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia. Brain, Behavior, and Immunity, 2024, 121, pp.178-188. ⟨10.1016/j.bbi.2024.07.025⟩. ⟨pasteur-04751831⟩
• 
  Antonietta Vilella, Benedetto Romoli, Martina Bodria, Stéphanie Pons, Uwe Maskos, et al.. Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice. Frontiers in Neuroscience, 2023, 17, pp.1097857. ⟨10.3389/fnins.2023.1097857⟩. ⟨pasteur-04551505⟩
• 
  Célia Raïs, Daniela Gaspar Santos, Giulia Sansone, Stéphane Blanchard, Jean-Pierre Bourgeois, et al.. Functional maturation of human iPSC-derived pyramidal neurons in vivo is dependent on proximity with the host tissue. Frontiers in Cellular Neuroscience, 2023, 23 (17), pp.1259712. ⟨10.3389/fncel.2023.1259712⟩. ⟨pasteur-04511558⟩
• 
  Estelle Darrau, Elise Jacquemet, Stéphanie Pons, Laurène Schlick, Marios Zouridakis, et al.. Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation. Translational Psychiatry, 2024, 14 (1), pp.146. ⟨10.1038/s41398-024-02853-8⟩. ⟨pasteur-04511551⟩

38

9